Plasma Cell Neoplasm at CIOC 2027

Plasma cell neoplasms are a group of disorders characterized by the abnormal proliferation of plasma cells, a type of white blood cell that produces antibodies. The most well-known plasma cell neoplasm is multiple myeloma, a cancer of plasma cells that infiltrates the bone marrow. Despite significant advancements in treatment, including novel immunotherapies and targeted therapies, multiple myeloma remains incurable and can be challenging to manage due to its heterogeneity and potential for relapse. Research in this field focuses on understanding the underlying genetic and molecular mechanisms driving plasma cell neoplasms, identifying novel therapeutic targets, and developing personalized treatment strategies to improve patient outcomes. Emerging therapies such as chimeric antigen receptor (CAR) T-cell therapy offer promising avenues for more effective and durable responses in patients with relapsed or refractory disease.